Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase 1 study of AS1411 (AGRO100) in advanced solid tumours.

Trial Profile

Phase 1 study of AS1411 (AGRO100) in advanced solid tumours.

Phase of Trial: Phase I

Latest Information Update: 09 Dec 2009

At a glance

  • Drugs ACT-GRO-777 (Primary)
  • Indications Non-small cell lung cancer; Renal cancer; Solid tumours
  • Focus Adverse reactions
  • Most Recent Events

    • 16 Apr 2009 Inclusion and exclusion criteria amended from ClinicalTrials.gov.
    • 16 Apr 2009 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health NCT00881244)
    • 16 Apr 2009 Actual patient number (30) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top